Last Updated:
Name Designation Appointment Date Status
Shankar Saha

Appointed as Director since November 2010

Director 02-Nov-2010 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Sumita Saha

Appointed as Director since November 2010

Director 02-Nov-2010 Current
Debmalya Saha

Appointed as Director since November 2010

Director 02-Nov-2010 Current

People Timeline

Explore the timeline of key personnel in Santon Drugs Rpivate Limited's leadership journey.

Loading...
Contact Details
  • Address 34, Chittaranjan Avenue Jaba Kusum Building, 2Nd Floor, Room No., -4, Kolkata West Bengal, 700072, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 700072
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Santon Drugs Rpivate Limited?
You can contact Santon Drugs Rpivate Limited through their registered address at 34, Chittaranjan Avenue Jaba Kusum Building, 2Nd Floor, Room No., -4, Kolkata West Bengal, 700072, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Santon Drugs Rpivate Limited?
The current directors of Santon Drugs Rpivate Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SHANKAR SAHA
  • SUMITA SAHA
  • DEBMALYA SAHA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available